Cargando…
The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review
Primary refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL) and mixed phenotype myeloid/T-cell acute leukemia have dismal prognoses. New treatment approaches, preferably targeting specific leukemic aberrations to overcome resistance, are urgently needed. The bright expression of the C...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628456/ https://www.ncbi.nlm.nih.gov/pubmed/37941558 http://dx.doi.org/10.3389/fonc.2023.1228481 |